Re: Derya Tilki, Ming-Hui Chen, Jing Wu, et al. Prostate-specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death. J Clin Oncol 2023;41:2428-35
1 Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Urology and Kidney Transplantation, University of Foggia, Foggia, Italy. Electronic address: ugofalagario@gmail.com.
2 Department of Urology, MD Anderson Cancer Center, Houston, TX, USA.
3 Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Division of Oncology/Unit of Urology, Soldera Prostate Cancer Laboratory, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
4 Department of Urology and Kidney Transplantation, University of Foggia, Foggia, Italy.
5 Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
6 Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Urology, MD Anderson Cancer Center, Houston, TX, USA; Departments of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
7 Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.